CN109706185A - The method and application of gene knockout are realized based on base editing system mutation initiation codon - Google Patents

The method and application of gene knockout are realized based on base editing system mutation initiation codon Download PDF

Info

Publication number
CN109706185A
CN109706185A CN201910105331.4A CN201910105331A CN109706185A CN 109706185 A CN109706185 A CN 109706185A CN 201910105331 A CN201910105331 A CN 201910105331A CN 109706185 A CN109706185 A CN 109706185A
Authority
CN
China
Prior art keywords
gene
target
sequence
abe
initiation codon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201910105331.4A
Other languages
Chinese (zh)
Other versions
CN109706185B (en
Inventor
马旭
李广磊
金孝华
王鑫杰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Science Technology Research Institute Of National Health And Family Planning Commission Of People's Republick Of China
Original Assignee
Science Technology Research Institute Of National Health And Family Planning Commission Of People's Republick Of China
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Science Technology Research Institute Of National Health And Family Planning Commission Of People's Republick Of China filed Critical Science Technology Research Institute Of National Health And Family Planning Commission Of People's Republick Of China
Priority to CN201910105331.4A priority Critical patent/CN109706185B/en
Publication of CN109706185A publication Critical patent/CN109706185A/en
Application granted granted Critical
Publication of CN109706185B publication Critical patent/CN109706185B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The method and application of gene knockout are realized based on base editing system mutation initiation codon.The gene knockout method is based on accurate single base editing technique, is mutated for encoding gene initiation codon ATG, prevents it from normally playing translation Initiation Function, to reach the knockout purpose to target gene.It specifically includes: it is selected to be located at gene to be knocked out translation initiation region 20bp-NGG or CCN-20bp target sequence, make that it includes complete initiation codon ATG;ABE or BE4 are navigated into target sequence using sgRNA sequence, makes the target single base in target gene initiation codon ATG that A to G, T to C or G to A mutation occur, initiation codon is destroyed, to realize gene knockout.Knockout technique of the invention is more efficient, more accurate and less undershooting-effect, realizes the knockout that gene can not be knocked out to part conventional method.

Description

Based on base editing system mutation initiation codon realize gene knockout method and Using
Technical field
The present invention relates to gene knockout strategies, more specifically, being related to the clpp gene based on initiation codon base editor Except method and its application.
Background technique
Gene knockout is so that the gene of an organism is lost or is lost by various molecule manipulations using molecular genetic techniques It is living, and then the function that cannot bring into normal play.
In traditional gene knockout, mainly completed by methods of homologous recombination.This method first has to building and includes institute The DNA vector that need to be mutated, the construct include and the target sequence at least homology of 2kb (Hall et al., 2009).It can lead to It crosses electrotransfection or building is mentioned and is delivered to stem cell by microinjection.Then itself repairing in time by DNA construct by cell It recombinates in cell DNA.However, this is an inefficient process, because intracellular homologous recombination only accounts for the 10 of DNA recombination-2It arrives 10-3(Hall et al.,2009)。
Then, the editing technique based on site specific nucleic acid enzyme has been developed.It include at present by Zinc finger nuclease technology (zinc finger nucleases, ZFNs) (Santiago et al., 2008), transcription activation factor sample effect nucleic acid zymotechnic (Transcription activator-like effector nucleases, TALENs) (Joung and Sander, 2012) and aggregation the short palindrome repetitive sequence system of aturegularaintervals (Clustered regularly interspaced short Palindromic repeats, CRISPRs) (Gaj et al., 2013).These three methods be related to accurately targeting DNA sequence dna with It introduces double-strand DNA cleavage (double-strand breaks, DSB), and then attempts to repair double-strand using the repair mechanism of cell Fracture is usually repaired by non-homologous end joining (non-homologous end joining, NHEJ).This reparation may Lead to the insertion or missing of base-pair, and then causes frameshift mutation.This mutation can make the gene lose function, to reach pair Knockout (knockout) purpose (Gaj et al., 2013) of specific gene.In addition, CRISPR under conditions of having template, leads to It crosses homologous recombination to be repaired (homology-directed repair, HDR), realize gene knock-in (knockin).The process It is more efficient compared with homologous recombination, and then the knockout for the realization allele that can be more easier.
CRISPR/Cas9 system, it is easy, efficient, inexpensive in view of it the features such as, become gene editing field it is with fastest developing speed, Most widely used technology has caused the revolution in gene editing field.Currently, CRISPR/Cas9 system has been successfully used to The researchs such as the knockout of DNA is knocked in, substituted, modifying, marking, and RNA modification and genetic transcription are adjusted (Hsu et al., 2014; Komor et al.,2017a).And be successfully applied to multiple species gene editing (Barrangou and Doudna, 2016;Komor et al.,2017a).But since HDR low efficiency (is integrated and is seldom occurred), and nonhomologous end jointing machine System is easy to produce radom insertion and deletes (indel), so that new base may be randomly incorporated near breaking point, so as to cause Inaccurate gene editing.In addition, CRISPR/Cas9 mediate gene editing have certain undershooting-effect (Gorski et al., 2017)。
Summary of the invention
An object of the present invention is to provide a kind of efficient accurately gene knockout strategy.
Base editing technique is based on novel gene edit tool constructed by CRISPR/Cas9 technology.There are born of the same parents phonetic at present Pyridine base editing machine (CBEs, cytosine base editors) and guanine base editing machine (ABEs, Adenine base editors).Cytosine base editing machine is to merge dCas9 or Cas9 nickase with rat cytidine deaminase APOBEC1, it Uracil (U) is converted by cytimidine (C) by deamination, later, by DNA replication dna or reparation, uracil (U) is turned It is melted into thymidine (T).Similarly, guanine (G) can be also converted to adenine (A).It can be smart in target gene It really is effectively introduced into point mutation, without double-strand DNA cleavage or any donor template, it is latent to show very big gene editing Power (Komor et al., 2016).Cytosine base editing machine is not required to cutting DNA and DSB, the indel of formation is caused to be lower than 1%, The gene editing of realization is more accurate (Komor et al., 2016);Moreover, this mode will miss the target, efficiency falls below nature 10 times of background, the gene editing of realization are safer (Nishida et al., 2016).Most common is BE3 (Komor Et al., 2016), more efficient BE4 (Komor et al., 2017b).
Adenine base editing machine induces the nucleotide variation of extensive target gene group locus in human cell (Gaudelli et al.,2017).In ABE system, TadA:TadA* heterodimer is by the mono- guidance RNA (sgRNA) of Cas9n/ Compound is guided to target site, and engineered TadA* is used as activity tRNA adenosine deaminase in single-stranded genomic DNA Inosine (I) is converted by adenine (A), then causes the guanine (G) in genome prominent during DNA reparation or DNA replication dna Become (Gaudelli et al., 2017).Similarly, thymidine (T) can be also converted to cytimidine (C).So far, BE and ABE system can programmably introduce all four conversions (C to T, G to A, A to G and T to C) on the target gene of genome, Greatly extend base editting function.
Accurate and specific single base editor of the inventor based on above-mentioned CBEs or ABEs System-mediated, ingehious design A kind of gene knockout strategy: it is mutated using BE4 system by G to A and target gene initiation codon ATG is sported into ATA;Or benefit ATG is sported by ACG or A to G mutation by T to C mutation with ABE system, ATG is sported into GTG.Pass through mutation initiation password Son, prevents the translation initiation of gene, to realize that gene silencing knocks out purpose.
According to the first aspect of the invention, a kind of gene knockout method is provided comprising:
Determine the initiation codon of gene to be knocked out, find design 20bp-NGG target sequence (PAM sequence), make it includes Complete initiation codon ATG;ABE is navigated into target sequence using sgRNA sequence, so that the target in initiation codon Single base A becomes G, so that initiation codon ATG is sported GTG, to realize gene knockout purpose.
Alternatively, it determines the initiation codon of gene to be knocked out, finds design CCN-20bp target sequence (PAM sequence Column), make that it includes complete initiation codon ATG;ABE, BE4 are navigated into target sequence using sgRNA sequence, so as to rise Target single base T in beginning codon becomes C or G becomes A, so that initiation codon ATG is sported ACG or ATA, to realize Gene knockout purpose.
If target single base A or T are preferably placed at 4-7 of target sequence using ABE, if using BE4, target list alkali Base G is preferably placed at 4-8 of target sequence;
The sgRNA sequence is and the complementary corresponding 20bp sequence of target sequence.
According to the present invention, ABE can be selected from pCMV-ABEmax SEQ ID NO.1
BE4 is selected from: pCMV-AncBE4max SEQ ID NO.2;pCMV-BE4max SEQ ID NO.3
Can be used for knocking out following 11 target genes according to the method for the present invention: people APOE, PD1, LAG3, TIGIT, VISTA, CD224, CD160, SOX9, HDAC1 and mouse TIM3 and LAG3, its corresponding sgRNA sequence respectively with sequence Target gene sequence shown in one to ten is complementary.
According to the second aspect of the invention, provide the above method cell line HEK293T carry out people APOE, PD1, The application of LAG3, TIGIT, VISTA, CD224, CD160, SOX9, HDAC1 gene knockout.
According to the third aspect of the invention we, provide the above method human T-cell carry out people APOE, PD1, LAG3, The application of TIGIT, VISTA, CD224, CD160, SOX9, HDAC1 gene knockout.
According to the fourth aspect of the invention, provide the isolated T cell or cell line obtained according to above-mentioned application or Their subculture.
According to the fifth aspect of the invention, a kind of kit for gene knockout is provided, including (with gene to be knocked out Above-mentioned sgRNA, ABE, BE3, BE4 and corresponding amplifing reagent accordingly).
The present invention utilizes the base editing technique developed on the basis of CRISPR/Cas9, passes through accurately A to G, T to C or G Single base mutation to A changes and destroys initiation codon ATG, thus establish it is more more efficient than CRISPR/Cas9, more accurate and The gene knockout strategy of less undershooting-effect.
Bibliography
Barrangou,R.,Doudna,J.A.,2016.Applications of CRISPR technologies in research and beyond.Nature Biotechnology 34,933.
Gaj,T.,Gersbach,C.A.,Barbas,C.F.,2013.ZFN,TALEN,and CRISPR/Cas-based methods for genome engineering.Trends in Biotechnology 31,397-405.
Gaudelli,N.M.,Komor,A.C.,Rees,H.A.,Packer,M.S.,Badran,A.H.,Bryson, D.I.,Liu,D.R.,2017.Programmable base editing of A·T to G·C in genomic DNA without DNA cleavage.Nature551,464.
Gorski,S.A.,Vogel,J.,Doudna,J.A.,2017.RNA-based recognition and targeting:sowing the seeds of specificity.Nature Reviews Molecular Cell Biology 18,215.
Hall,B.,Limaye,A.,Kulkarni,A.B.,2009.Overview:generation of gene knockout mice.Curr Protoc Cell Biol Chapter 19,Unit 19 12 19 12 11-17.
Hsu,Patrick D.,Lander,Eric S.,Zhang,F.,2014.Development and Applications of CRISPR-Cas9for Genome Engineering.Cell 157,1262-1278.
Joung,J.K.,Sander,J.D.,2012.TALENs:a widely applicable technology for targeted genome editing.Nature Reviews Molecular Cell Biology 14,49.
Komor,A.C.,Badran,A.H.,Liu,D.R.,2017a.CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes.Cell 168,20-36.
Komor,A.C.,Kim,Y.B.,Packer,M.S.,Zuris,J.A.,Liu,D.R.,2016.Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage.Nature 533,420.
Komor,A.C.,Zhao,K.T.,Packer,M.S.,Gaudelli,N.M.,Waterbury,A.L.,Koblan, L.W.,Kim,Y.B.,Badran,A.H.,Liu,D.R.,2017b.Improved base excision repair inhibition and bacteriophage Mu Gam protein yields C:G-to-T:A base editors with higher efficiency and product purity.Sci Adv 3,eaao4774.
Nishida,K.,Arazoe,T.,Yachie,N.,Banno,S.,Kakimoto,M.,Tabata,M., Mochizuki,M.,Miyabe,A.,Araki,M.,Hara,K.Y.,Shimatani,Z.,Kondo,A.,2016.Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems.Science 353.
Ren,B.,Yan,F.,Kuang,Y.,Li,N.,Zhang,D.,Zhou,X.,Lin,H.,Zhou,H., 2018.Improved Base Editor for Efficiently Inducing Genetic Variations in Rice with CRISPR/Cas9-Guided Hyperactive hAID Mutant.Molecular Plant 11,623-626.
Santiago,Y.,Chan,E.,Liu,P.-Q.,Orlando,S.,Zhang,L.,Urnov,F.D.,Holmes, M.C.,Guschin,D.,Waite,A.,Miller,J.C.,Rebar,E.J.,Gregory,P.D.,Klug,A., Collingwood,T.N.,2008.
Targeted gene knockout in mammalian cells by using engineered zinc- finger nucleases.Proceedings of the National Academy of Sciences 105,5809- 5814.
Detailed description of the invention
Fig. 1 is that according to the present invention be mutated using ATG realizes that target gene knocks out schematic diagram;
Fig. 2 is pCMV-AncBE4max structural schematic diagram used in the present invention;
Fig. 3 is pCMV-BE4max structural schematic diagram used in the present invention;
Fig. 4 is pCMV-ABEmax structural schematic diagram used in the present invention;
Fig. 5 is present invention transfection sgRNA and ABE or BE4 plasmid, FCM analysis GFP positive exemplary diagram;
Fig. 6 is gene editing efficiency and editing sites analysis chart in the present invention, by taking HDAC1 gene as an example;
Fig. 7 is gene editing efficiency and editing sites analysis chart in the present invention, by taking SOX9 gene as an example;
Fig. 8 is to obtain the monoclonal cell editor effect that target gene initiation codon ATG is edited by sorting in the present invention Rate and editing sites analysis, by taking HDAC1 gene as an example;
Fig. 9 is to obtain the monoclonal cell editor effect that target gene initiation codon ATG is edited by sorting in the present invention Rate and editing sites analysis, by taking SOX9 gene as an example;
Figure 10 is to obtain the monoclonal cell purpose base that target gene initiation codon ATG is edited by sorting in the present invention The Western blot of cause is analyzed, by taking HDAC1 gene as an example.
Specific embodiment
Clear, complete description is carried out to embodiment of the present invention below in conjunction with embodiment, it is clear that described reality It applies example and is merely to illustrate a part of the embodiments of the present invention, and be not construed as limiting the scope of the invention.It is not specified in embodiment Actual conditions person carries out according to conventional conditions or manufacturer's recommended conditions.Reagents or instruments used without specified manufacturer, It is considered as the conventional products that can be obtained by commercially available purchase.
The foregoing is merely present pre-ferred embodiments, are not intended to limit the invention, all in spirit of the invention Within principle, any modification, equivalent replacement, improvement and so on be should all be included in the protection scope of the present invention.
Base fixed point editor is to be navigated to ABE or BE4 or site-specific target site using sgRNA, target gene specific The selection and design of sgRNA is the key that place of the invention.The present invention selects design sgRNA as follows:
20bp-NGG CCN-20bp target sequence (the PAM sequence comprising initiation codon ATG that is selected then knocking out gene Column), if using ABE, target single base A or T are preferably placed at 4-7 of target sequence, if target single base G is excellent using BE4 Bit selecting is in 4-8 (Fig. 1-Fig. 4) of target sequence.
Preparation 20bp sgRNA sequence corresponding with target sequence complementation.
For 11 target genes --- people APOE, PD1, LAG3, TIGIT, VISTA, CD224, CD160, SOX9, HDAC1 and mouse TIM3 and LAG3, the present invention selectes following target gene sequences, and to design corresponding sgRNA, (runic is indicated PAM;Lower stroke of expression Candidate Mutant coding of italic):
One .hAPOE
ABE T to C
Sg-1:SEQ ID NO.4
ABE A to G
Sg-2:SEQ ID NO.5
Two .hPD1
ABE A to G
Sg-1:SEQ ID NO.6
Three .hLAG3
BE4 G to A
Sg-1:SEQ ID NO.7
ABE T to C
Sg-2:SEQ ID NO.8
Four .hTIGIT
ABE T to C
Sg-1:SEQ ID NO.9
BE4 G to A
Sg-2:SEQ ID NO.10
Five .hVISTA
ABE A to G
Sg-1:SEQ ID NO.11
Six .hCD224
ABE A to G
Sg-1:SEQ ID NO.12
Seven .hCD160
ABE A to G
Sg-1:SEQ ID NO.13
Eight .hSOX9
BE4 G to A
Sg-1:SEQ ID NO.14
Nine .mTIM3
BE4 G to A
Sg-1:SEQ ID NO.15
ABE T to C
Sg-2:SEQ ID NO.16
Ten .mLAG3
BE4G to A
Sg-1:SEQ ID NO.17
ABE T to C
Sg-2:SEQ ID NO.18
11 .HDAC1
ABE A to G
Sg-1:SEQ ID NO.19
For above-mentioned selected target gene sequence, people APOE (2), PD1, LAG3 (2), TIGIT (2), VISTA, CD224, CD160, SOX9, HDAC1 and mouse TIM3 (2) and LAG3 (2) construct corresponding sgRNA expression Different sgRNA is directed respectively into pGL3-U6-sgRNA carrier, SEQ ID NO.20 by carrier.
Embodiment 1
The base editor that ABE or BE4 is mediated is carried out on cell strain, mutation initiation codon realizes gene knockout.
The present invention carries out the culture and transfection of eukaryotic cells, carries out the gene knockout of cell strain (by electricity turn or rouge Plasmids).Below with HEK293T cell, to people APOE, PD1, LAG3, TIGIT, VISTA, CD224, CD160, SOX9, It demonstrates for the isogenic liposome transfection method of HDAC1.
(1) in DMEM culture solution of the HEK293T cell inoculation culture containing 10%FBS (HyClone, SH30022.01B), In contain penicillin (100U/ml) and streptomycin (100 μ g/ml).
(2) day before transfection divides cell to 6 orifice plates.Next day is transfected when density is to 70%-80%.
(3) according to LipofectamineTM2000Transfection Reagent's (Invitrogen, 11668-019) Operation manual mixes 2 μ g ABE or BE4 plasmids pGL3-U6-sgRNA plasmid corresponding with 2 μ g, and cotransfection is into cell, 6- Liquid is changed after 8 hours, cell is collected after 72 hours, and cell transfecting efficiency is determined (Fig. 5) by flow type analyzer.
(4) genotyping
A, part cell is collected to use in lysate (10 μM of Tris-HCl, 0.4M NaCl, 2 μM of EDTA, 1%SDS) The cracking digestion of 100 μ g/ml Proteinase Ks, phenol-chloroform extracting are dissolved into 50 μ l ddH2In O.
B, PCR amplification is carried out using pair of primers N-For and N-Rev, purifies acquisition with AxyPrep PCR cleanup PCR recovery product takes 200ng to be uniformly diluted to 20 μ l and is denaturalized, is annealed, program such as: 95 DEG C, 5min;95-85℃at-2 ℃/s;85-25℃at-0.1℃/s;hold at 4℃.
C, the PCR recovery product of acquisition is carried out with rTaq plus A reacts.Add A reaction system are as follows:
700-800ng PCR recovery product
5μl 10X Buffer(Mg2+PLUS)
4μl dNTP
0.5μl rTaq(TAKARA,R001AM)
Moisturizing is to 50 μ l systems.
After 37 DEG C incubate 30 minutes, 1 μ l product and pMD19-T vector (TAKARA, 3271) is taken to connect and convert DH5 Competent cell (TransGen, CD201).
D, each mutant target gene is sequenced with universal primer M13-F in picking monoclonal, and sequencing result is following, and (runic indicates PAM;Italic indicates mutation coding;Lower stroke of expression mutating alkali yl of italic):
1.hAPOE
Sg-1:
Mut:
Sg-2:
Mut:
2.hPD1
Sg-1:
Mut:
3.hLAG3
Sg-1:
Mut:
Sg-2:
Mut:
4.hTIGIT
Sg-1:
Mut:
Sg-2:
Mut:
5.hVISTA
Sg-1:
Mut:
6.hCD224
Sg-1:
Mut:
(7.hCD160 Fig. 6, Fig. 8)
Sg-1:
Mut:
8.hSOX9
Sg-1:
Mut:
(9.HDAC1 Fig. 7, Fig. 9)
Sg-1:
Mut:
(5) Western blot detection knocks out effect
Further, we carry out western blot detection to the monoclonal cell of select HDAC1, HDAC1's Albumen can't detect (Figure 10), illustrates to be mutated ATG from protein level, can successfully realize the knockout of target gene.
The result shows that: the base mutation of sgRNA targeting has occurred in target gene initiation codon, translates it from playing Beginning effect is realized to the success of people's APOE, PD1, LAG3, TIGIT, VISTA, CD224, CD160, SOX9, HDAC1 gene knockout.
Embodiment 2
The base editor that ABE or BE4 is mediated is carried out on primary cell, mutation initiation codon realizes gene knockout.
Routinely operate, with the T cell of people into the gene knockout (passing through electrotransfection or liposome transfection) of primary cell, with For electrotransfection.
(1) PBMC cell isolates and purifies:
A, peripheral blood is acquired with anticoagulant tube, rocking in acquisition is sufficiently mixed peripheral blood with anti-coagulants;
B, peripheral blood cells mix in equal volume with lymphocyte separation medium, centrifugation, the tunica albuginea confluent monolayer cells after drawing centrifugation;
C, it is centrifuged after mixing obtained tunica albuginea confluent monolayer cells with serum-free cell culture medium 1640, collects sedimentation cell, i.e., For PBMC cell.
Above-mentioned separation process repeats three times.
(2) enrichment of CD3 positive cell
A, PBMC cell concentration is adjusted to 50x106cell/ml。
B, 50 μ l of CD3+enriched antibodies cocktail is added by every 1ml, 5 points is stored at room temperature after mixing Clock.
C, 150 μ l of magnet is added by every 1ml, is stored at room temperature after mixing 10 minutes,
D, centrifuge tube is placed on magnetic frame and stands 5 minutes, draw upper cell suspension into new 15ml centrifuge tube.
E, it is primary to repeat the operation.
F, room temperature collects cell with 300g centrifugation 10 minutes.
G, cell count.
(3) electricity of CD3 positive cell turns
A, configuration electricity swivel system
8 μ g BE3, BE4 or ABE plasmid pGL3-U6-sgRNA matter corresponding with 8 μ g are separately added into 1.5ml centrifuge tube Grain, and turn kit specification requirement according to Lonza Amaxa electricity, 82 μ l electricity are added and turn buffer and 18 μ l Supplement1 is mixed.
B, 20X10 is collected6Into 15ml centrifuge tube, 300g is centrifuged 10 minutes a cell, abandons supernatant.
C, buffer solution mixture is turned with the plasmid electricity prepared in A and cell is resuspended, and be transferred in electric revolving cup.
D, electricity is carried out using instrument Lonza 2B, U-014 program to turn.
E, the cell after electricity turns is transferred quickly in the AIM-V culture medium added with 10%FBS preheated in advance, and 37 degree It is cultivated 2 hours in 5% carbon dioxide incubator.
F, the cell after electricity turns changes liquid entirely, with 1X106Cell, overnight incubation is resuspended in the density of a/ml.
(4) the activation culture of T cell
A, after electricity turns culture 24 hours, 100U/ml IL-2 is added into culture medium, and CD3/ is added according to the ratio of 1:1 CD28dynabeads activates T cell.
B, liquid is partly changed to cell, or adds IL-2 within every two day, cell density maintains 1X10 always6A/ml.
C, after activating 5 days, T cell is collected into 15ml centrifuge tube, and centrifuge tube is placed in magnetic frame, it slowly will be upper It is transferred to clearly in another clean 15ml centrifuge tube, it is primary to repeat this step.
D, room temperature is centrifuged 300g, 10 minutes, abandons supernatant, and with 10%FBS, 300U/ml IL-2AIM-V culture medium is resuspended thin Born of the same parents, density domination is in 1X106A/ml.
E, liquid is partly changed to cell, or adds IL-2, and count within every two day, cell maintains 1X106A/ml.
(5) genotyping
A, receiving portions cell is in lysate (10 μM of Tris-HCl, 0.4M NaCl, 2 μM of EDTA, 1%SDS) with 100 μ After the cracking digestion of g/ml Proteinase K, it is dissolved into 50 μ l deionized waters after phenol-chloroform extracting.
B, PCR amplification is carried out using pair of primers N-For and N-Rev, purifies acquisition with AxyPrep PCR cleanup PCR recovery product takes 200ng to be uniformly diluted to 20 μ l and is denaturalized, is annealed, program such as: 95 DEG C, 5min;95-85℃at-2 ℃/s;85-25℃at-0.1℃/s;hold at 4℃.
C, the PCR recovery product of acquisition is carried out with rTaq plus A reacts.Add A reaction system are as follows:
700-800ng PCR recovery product
5μl 10X Buffer(Mg2+PLUS)
4μl dNTP
0.5μl rTaq(TAKARA,R001AM)
Moisturizing is to 50 μ l systems.
After 37 DEG C incubate 30 minutes, 1 μ l product and pMD19-T vector (TAKARA, 3271) is taken to connect and convert DH5 Competent cell (TransGen, CD201).
D, each mutant target gene of T cell, following (the runic table of sequencing result is sequenced with universal primer M13-F in picking monoclonal Show PAM;Italic indicates Candidate Mutant coding;Lower stroke of expression mutating alkali yl of italic):
1.hAPOE
Sg-1:
Mut:
Sg-2:
Mut:
2.hPD1
Sg-1:
Mut:
3.hLAG3
Sg-1:
Mut:
Sg-2:
Mut:
4.hTIGIT
Sg-1:
Mut:
Sg-2:
Mut:
5.hVISTA
Sg-1:
Mut:
6.hCD224
Sg-1:
Mut:
7.hCD160
Sg-1:
Mut:
8.hSOX9
Sg-1:
Mut:
9.HDAC1
Sg-1:
Mut:
The result shows that: the base mutation of sgRNA targeting has occurred in target gene, and gene start codon ATG introduces mutation, real Now to the success of the gene knockouts such as people APOE, PD1, LAG3, TIGIT, VISTA, CD224, CD160, SOX9, HDAC1.
Embodiment 3
Construct the knock out mice that ABE or BE4 is mediated
Routinely operation carries out embryo collection, microinjection, Embryo Culture and the embryo transfer etc. of mouse.With TIM3 and Knock out mice is constructed for LAG3 gene.
(1) microinjection: mRNA the and TIM3 specificity sgRNA that fertilized eggs inject ABE or BE4 respectively (corresponds to above-mentioned Sequence nine) or ABE or BE4 mRNA and LAG3 specificity sgRNA (correspond to above-mentioned sequence ten).It is conventional to carry out embryo transfer;
(2) genotyping: conventional mouse cuts tail and extracts genomic DNA, and PCR distinguishes amplification coding region, and Sanger is surveyed Sequence, sequencing result is following, and (runic indicates PAM;Italic indicates mutation coding;Lower stroke of expression mutating alkali yl of italic):
10.mTIM3
Sg-1:
Mut:
Sg-2:
Mut:
11.mLAG3
Sg-1:
Mut:
Sg-2:
Mut:
The above results confirm TIM3 and LAG3 initiation codon introduce mutation, building TIM3 and LAG3 knock-out mice at Function.
Sequence table
<110>national health State Family Planning Commission Institute Of Science And Technology
<120>method and application of gene knockout are realized based on base editing system mutation initiation codon
<160> 2
<170> SIPOSequenceListing 1.0
<210> 1
<211> 8811
<212> DNA
<213>artificial sequence ()
<400> 1
atatgccaag tacgccccct attgacgtca atgacggtaa atggcccgcc tggcattatg 60
cccagtacat gaccttatgg gactttccta cttggcagta catctacgta ttagtcatcg 120
ctattaccat ggtgatgcgg ttttggcagt acatcaatgg gcgtggatag cggtttgact 180
cacggggatt tccaagtctc caccccattg acgtcaatgg gagtttgttt tggcaccaaa 240
atcaacggga ctttccaaaa tgtcgtaaca actccgcccc attgacgcaa atgggcggta 300
ggcgtgtacg gtgggaggtc tatataagca gagctggttt agtgaaccgt cagatccgct 360
agagatccgc ggccgctaat acgactcact atagggagag ccgccaccat gaaacggaca 420
gccgacggaa gcgagttcga gtcaccaaag aagaagcgga aagtctctga agtcgagttt 480
agccacgagt attggatgag gcacgcactg accctggcaa agcgagcatg ggatgaaaga 540
gaagtccccg tgggcgccgt gctggtgcac aacaatagag tgatcggaga gggatggaac 600
aggccaatcg gccgccacga ccctaccgca cacgcagaga tcatggcact gaggcaggga 660
ggcctggtca tgcagaatta ccgcctgatc gatgccaccc tgtatgtgac actggagcca 720
tgcgtgatgt gcgcaggagc aatgatccac agcaggatcg gaagagtggt gttcggagca 780
cgggacgcca agaccggcgc agcaggctcc ctgatggatg tgctgcacca ccccggcatg 840
aaccaccggg tggagatcac agagggaatc ctggcagacg agtgcgccgc cctgctgagc 900
gatttcttta gaatgcggag acaggagatc aaggcccaga agaaggcaca gagctccacc 960
gactctggag gatctagcgg aggatcctct ggaagcgaga caccaggcac aagcgagtcc 1020
gccacaccag agagctccgg cggctcctcc ggaggatcct ctgaggtgga gttttcccac 1080
gagtactgga tgagacatgc cctgaccctg gccaagaggg cacgcgatga gagggaggtg 1140
cctgtgggag ccgtgctggt gctgaacaat agagtgatcg gcgagggctg gaacagagcc 1200
atcggcctgc acgacccaac agcccatgcc gaaattatgg ccctgagaca gggcggcctg 1260
gtcatgcaga actacagact gattgacgcc accctgtacg tgacattcga gccttgcgtg 1320
atgtgcgccg gcgccatgat ccactctagg atcggccgcg tggtgtttgg cgtgaggaac 1380
gcaaaaaccg gcgccgcagg ctccctgatg gacgtgctgc actaccccgg catgaatcac 1440
cgcgtcgaaa ttaccgaggg aatcctggca gatgaatgtg ccgccctgct gtgctatttc 1500
tttcggatgc ctagacaggt gttcaatgct cagaagaagg cccagagctc caccgactcc 1560
ggaggatcta gcggaggctc ctctggctct gagacacctg gcacaagcga gagcgcaaca 1620
cctgaaagca gcgggggcag cagcgggggg tcagacaaga agtacagcat cggcctggcc 1680
atcggcacca actctgtggg ctgggccgtg atcaccgacg agtacaaggt gcccagcaag 1740
aaattcaagg tgctgggcaa caccgaccgg cacagcatca agaagaacct gatcggagcc 1800
ctgctgttcg acagcggcga aacagccgag gccacccggc tgaagagaac cgccagaaga 1860
agatacacca gacggaagaa ccggatctgc tatctgcaag agatcttcag caacgagatg 1920
gccaaggtgg acgacagctt cttccacaga ctggaagagt ccttcctggt ggaagaggat 1980
aagaagcacg agcggcaccc catcttcggc aacatcgtgg acgaggtggc ctaccacgag 2040
aagtacccca ccatctacca cctgagaaag aaactggtgg acagcaccga caaggccgac 2100
ctgcggctga tctatctggc cctggcccac atgatcaagt tccggggcca cttcctgatc 2160
gagggcgacc tgaaccccga caacagcgac gtggacaagc tgttcatcca gctggtgcag 2220
acctacaacc agctgttcga ggaaaacccc atcaacgcca gcggcgtgga cgccaaggcc 2280
atcctgtctg ccagactgag caagagcaga cggctggaaa atctgatcgc ccagctgccc 2340
ggcgagaaga agaatggcct gttcggaaac ctgattgccc tgagcctggg cctgaccccc 2400
aacttcaaga gcaacttcga cctggccgag gatgccaaac tgcagctgag caaggacacc 2460
tacgacgacg acctggacaa cctgctggcc cagatcggcg accagtacgc cgacctgttt 2520
ctggccgcca agaacctgtc cgacgccatc ctgctgagcg acatcctgag agtgaacacc 2580
gagatcacca aggcccccct gagcgcctct atgatcaaga gatacgacga gcaccaccag 2640
gacctgaccc tgctgaaagc tctcgtgcgg cagcagctgc ctgagaagta caaagagatt 2700
ttcttcgacc agagcaagaa cggctacgcc ggctacattg acggcggagc cagccaggaa 2760
gagttctaca agttcatcaa gcccatcctg gaaaagatgg acggcaccga ggaactgctc 2820
gtgaagctga acagagagga cctgctgcgg aagcagcgga ccttcgacaa cggcagcatc 2880
ccccaccaga tccacctggg agagctgcac gccattctgc ggcggcagga agatttttac 2940
ccattcctga aggacaaccg ggaaaagatc gagaagatcc tgaccttccg catcccctac 3000
tacgtgggcc ctctggccag gggaaacagc agattcgcct ggatgaccag aaagagcgag 3060
gaaaccatca ccccctggaa cttcgaggaa gtggtggaca agggcgcttc cgcccagagc 3120
ttcatcgagc ggatgaccaa cttcgataag aacctgccca acgagaaggt gctgcccaag 3180
cacagcctgc tgtacgagta cttcaccgtg tataacgagc tgaccaaagt gaaatacgtg 3240
accgagggaa tgagaaagcc cgccttcctg agcggcgagc agaaaaaggc catcgtggac 3300
ctgctgttca agaccaaccg gaaagtgacc gtgaagcagc tgaaagagga ctacttcaag 3360
aaaatcgagt gcttcgactc cgtggaaatc tccggcgtgg aagatcggtt caacgcctcc 3420
ctgggcacat accacgatct gctgaaaatt atcaaggaca aggacttcct ggacaatgag 3480
gaaaacgagg acattctgga agatatcgtg ctgaccctga cactgtttga ggacagagag 3540
atgatcgagg aacggctgaa aacctatgcc cacctgttcg acgacaaagt gatgaagcag 3600
ctgaagcggc ggagatacac cggctggggc aggctgagcc ggaagctgat caacggcatc 3660
cgggacaagc agtccggcaa gacaatcctg gatttcctga agtccgacgg cttcgccaac 3720
agaaacttca tgcagctgat ccacgacgac agcctgacct ttaaagagga catccagaaa 3780
gcccaggtgt ccggccaggg cgatagcctg cacgagcaca ttgccaatct ggccggcagc 3840
cccgccatta agaagggcat cctgcagaca gtgaaggtgg tggacgagct cgtgaaagtg 3900
atgggccggc acaagcccga gaacatcgtg atcgaaatgg ccagagagaa ccagaccacc 3960
cagaagggac agaagaacag ccgcgagaga atgaagcgga tcgaagaggg catcaaagag 4020
ctgggcagcc agatcctgaa agaacacccc gtggaaaaca cccagctgca gaacgagaag 4080
ctgtacctgt actacctgca gaatgggcgg gatatgtacg tggaccagga actggacatc 4140
aaccggctgt ccgactacga tgtggaccat atcgtgcctc agagctttct gaaggacgac 4200
tccatcgaca acaaggtgct gaccagaagc gacaagaacc ggggcaagag cgacaacgtg 4260
ccctccgaag aggtcgtgaa gaagatgaag aactactggc ggcagctgct gaacgccaag 4320
ctgattaccc agagaaagtt cgacaatctg accaaggccg agagaggcgg cctgagcgaa 4380
ctggataagg ccggcttcat caagagacag ctggtggaaa cccggcagat cacaaagcac 4440
gtggcacaga tcctggactc ccggatgaac actaagtacg acgagaatga caagctgatc 4500
cgggaagtga aagtgatcac cctgaagtcc aagctggtgt ccgatttccg gaaggatttc 4560
cagttttaca aagtgcgcga gatcaacaac taccaccacg cccacgacgc ctacctgaac 4620
gccgtcgtgg gaaccgccct gatcaaaaag taccctaagc tggaaagcga gttcgtgtac 4680
ggcgactaca aggtgtacga cgtgcggaag atgatcgcca agagcgagca ggaaatcggc 4740
aaggctaccg ccaagtactt cttctacagc aacatcatga actttttcaa gaccgagatt 4800
accctggcca acggcgagat ccggaagcgg cctctgatcg agacaaacgg cgaaaccggg 4860
gagatcgtgt gggataaggg ccgggatttt gccaccgtgc ggaaagtgct gagcatgccc 4920
caagtgaata tcgtgaaaaa gaccgaggtg cagacaggcg gcttcagcaa agagtctatc 4980
ctgcccaaga ggaacagcga taagctgatc gccagaaaga aggactggga ccctaagaag 5040
tacggcggct tcgacagccc caccgtggcc tattctgtgc tggtggtggc caaagtggaa 5100
aagggcaagt ccaagaaact gaagagtgtg aaagagctgc tggggatcac catcatggaa 5160
agaagcagct tcgagaagaa tcccatcgac tttctggaag ccaagggcta caaagaagtg 5220
aaaaaggacc tgatcatcaa gctgcctaag tactccctgt tcgagctgga aaacggccgg 5280
aagagaatgc tggcctctgc cggcgaactg cagaagggaa acgaactggc cctgccctcc 5340
aaatatgtga acttcctgta cctggccagc cactatgaga agctgaaggg ctcccccgag 5400
gataatgagc agaaacagct gtttgtggaa cagcacaagc actacctgga cgagatcatc 5460
gagcagatca gcgagttctc caagagagtg atcctggccg acgctaatct ggacaaagtg 5520
ctgtccgcct acaacaagca ccgggataag cccatcagag agcaggccga gaatatcatc 5580
cacctgttta ccctgaccaa tctgggagcc cctgccgcct tcaagtactt tgacaccacc 5640
atcgaccgga agaggtacac cagcaccaaa gaggtgctgg acgccaccct gatccaccag 5700
agcatcaccg gcctgtacga gacacggatc gacctgtctc agctgggagg tgactctggc 5760
ggctcaaaaa gaaccgccga cggcagcgaa ttcgagccca agaagaagag gaaagtctaa 5820
ccggtcatca tcaccatcac cattgagttt aaacccgctg atcagcctcg actgtgcctt 5880
ctagttgcca gccatctgtt gtttgcccct cccccgtgcc ttccttgacc ctggaaggtg 5940
ccactcccac tgtcctttcc taataaaatg aggaaattgc atcgcattgt ctgagtaggt 6000
gtcattctat tctggggggt ggggtggggc aggacagcaa gggggaggat tgggaagaca 6060
atagcaggca tgctggggat gcggtgggct ctatggcttc tgaggcggaa agaaccagct 6120
ggggctcgat accgtcgacc tctagctaga gcttggcgta atcatggtca tagctgtttc 6180
ctgtgtgaaa ttgttatccg ctcacaattc cacacaacat acgagccgga agcataaagt 6240
gtaaagccta gggtgcctaa tgagtgagct aactcacatt aattgcgttg cgctcactgc 6300
ccgctttcca gtcgggaaac ctgtcgtgcc agctgcatta atgaatcggc caacgcgcgg 6360
ggagaggcgg tttgcgtatt gggcgctctt ccgcttcctc gctcactgac tcgctgcgct 6420
cggtcgttcg gctgcggcga gcggtatcag ctcactcaaa ggcggtaata cggttatcca 6480
cagaatcagg ggataacgca ggaaagaaca tgtgagcaaa aggccagcaa aaggccagga 6540
accgtaaaaa ggccgcgttg ctggcgtttt tccataggct ccgcccccct gacgagcatc 6600
acaaaaatcg acgctcaagt cagaggtggc gaaacccgac aggactataa agataccagg 6660
cgtttccccc tggaagctcc ctcgtgcgct ctcctgttcc gaccctgccg cttaccggat 6720
acctgtccgc ctttctccct tcgggaagcg tggcgctttc tcatagctca cgctgtaggt 6780
atctcagttc ggtgtaggtc gttcgctcca agctgggctg tgtgcacgaa ccccccgttc 6840
agcccgaccg ctgcgcctta tccggtaact atcgtcttga gtccaacccg gtaagacacg 6900
acttatcgcc actggcagca gccactggta acaggattag cagagcgagg tatgtaggcg 6960
gtgctacaga gttcttgaag tggtggccta actacggcta cactagaaga acagtatttg 7020
gtatctgcgc tctgctgaag ccagttacct tcggaaaaag agttggtagc tcttgatccg 7080
gcaaacaaac caccgctggt agcggtggtt tttttgtttg caagcagcag attacgcgca 7140
gaaaaaaagg atctcaagaa gatcctttga tcttttctac ggggtctgac actcagtgga 7200
acgaaaactc acgttaaggg attttggtca tgagattatc aaaaaggatc ttcacctaga 7260
tccttttaaa ttaaaaatga agttttaaat caatctaaag tatatatgag taaacttggt 7320
ctgacagtta ccaatgctta atcagtgagg cacctatctc agcgatctgt ctatttcgtt 7380
catccatagt tgcctgactc cccgtcgtgt agataactac gatacgggag ggcttaccat 7440
ctggccccag tgctgcaatg ataccgcgag acccacgctc accggctcca gatttatcag 7500
caataaacca gccagccgga agggccgagc gcagaagtgg tcctgcaact ttatccgcct 7560
ccatccagtc tattaattgt tgccgggaag ctagagtaag tagttcgcca gttaatagtt 7620
tgcgcaacgt tgttgccatt gctacaggca tcgtggtgtc acgctcgtcg tttggtatgg 7680
cttcattcag ctccggttcc caacgatcaa ggcgagttac atgatccccc atgttgtgca 7740
aaaaagcggt tagctccttc ggtcctccga tcgttgtcag aagtaagttg gccgcagtgt 7800
tatcactcat ggttatggca gcactgcata attctcttac tgtcatgcca tccgtaagat 7860
gcttttctgt gactggtgag tactcaacca agtcattctg agaatagtgt atgcggcgac 7920
cgagttgctc ttgcccggcg tcaatacggg ataataccgc gccacatagc agaactttaa 7980
aagtgctcat cattggaaaa cgttcttcgg ggcgaaaact ctcaaggatc ttaccgctgt 8040
tgagatccag ttcgatgtaa cccactcgtg cacccaactg atcttcagca tcttttactt 8100
tcaccagcgt ttctgggtga gcaaaaacag gaaggcaaaa tgccgcaaaa aagggaataa 8160
gggcgacacg gaaatgttga atactcatac tcttcctttt tcaatattat tgaagcattt 8220
atcagggtta ttgtctcatg agcggataca tatttgaatg tatttagaaa aataaacaaa 8280
taggggttcc gcgcacattt ccccgaaaag tgccacctga cgtcgacgga tcgggagatc 8340
gatctcccga tcccctaggg tcgactctca gtacaatctg ctctgatgcc gcatagttaa 8400
gccagtatct gctccctgct tgtgtgttgg aggtcgctga gtagtgcgcg agcaaaattt 8460
aagctacaac aaggcaaggc ttgaccgaca attgcatgaa gaatctgctt agggttaggc 8520
gttttgcgct gcttcgcgat gtacgggcca gatatacgcg ttgacattga ttattgacta 8580
gttattaata gtaatcaatt acggggtcat tagttcatag cccatatatg gagttccgcg 8640
ttacataact tacggtaaat ggcccgcctg gctgaccgcc caacgacccc cgcccattga 8700
cgtcaataat gacgtatgtt cccatagtaa cgccaatagg gactttccat tgacgtcaat 8760
gggtggagta tttacggtaa actgcccact tggcagtaca tcaagtgtat c 8811
<210> 2
<211> 8961
<212> DNA
<213>artificial sequence ()
<400> 2
atatgccaag tacgccccct attgacgtca atgacggtaa atggcccgcc tggcattatg 60
cccagtacat gaccttatgg gactttccta cttggcagta catctacgta ttagtcatcg 120
ctattaccat ggtgatgcgg ttttggcagt acatcaatgg gcgtggatag cggtttgact 180
cacggggatt tccaagtctc caccccattg acgtcaatgg gagtttgttt tggcaccaaa 240
atcaacggga ctttccaaaa tgtcgtaaca actccgcccc attgacgcaa atgggcggta 300
ggcgtgtacg gtgggaggtc tatataagca gagctggttt agtgaaccgt cagatccgct 360
agagatccgc ggccgctaat acgactcact atagggagag ccgccaccat gaaacggaca 420
gccgacggaa gcgagttcga gtcaccaaag aagaagcgga aagtcagcag tgaaaccgga 480
ccagtggcag tggacccaac cctgaggaga cggattgagc cccatgaatt tgaagtgttc 540
tttgacccaa gggagctgag gaaggagaca tgcctgctgt acgagatcaa gtggggcaca 600
agccacaaga tctggcgcca cagctccaag aacaccacaa agcacgtgga agtgaatttc 660
atcgagaagt ttacctccga gcggcacttc tgcccctcta ccagctgttc catcacatgg 720
tttctgtctt ggagcccttg cggcgagtgt tccaaggcca tcaccgagtt cctgtctcag 780
caccctaacg tgaccctggt catctacgtg gcccggctgt atcaccacat ggaccagcag 840
aacaggcagg gcctgcgcga tctggtgaat tctggcgtga ccatccagat catgacagcc 900
ccagagtacg actattgctg gcggaacttc gtgaattatc cacctggcaa ggaggcacac 960
tggccaagat acccacccct gtggatgaag ctgtatgcac tggagctgca cgcaggaatc 1020
ctgggcctgc ctccatgtct gaatatcctg cggagaaagc agccccagct gacatttttc 1080
accattgctc tgcagtcttg tcactatcag cggctgcctc ctcatattct gtgggctaca 1140
ggcctgaagt ctggaggatc tagcggagga tcctctggca gcgagacacc aggaacaagc 1200
gagtcagcaa caccagagag cagtggcggc agcagcggcg gcagcgacaa gaagtacagc 1260
atcggcctgg ccatcggcac caactctgtg ggctgggccg tgatcaccga cgagtacaag 1320
gtgcccagca agaaattcaa ggtgctgggc aacaccgacc ggcacagcat caagaagaac 1380
ctgatcggag ccctgctgtt cgacagcggc gaaacagccg aggccacccg gctgaagaga 1440
accgccagaa gaagatacac cagacggaag aaccggatct gctatctgca agagatcttc 1500
agcaacgaga tggccaaggt ggacgacagc ttcttccaca gactggaaga gtccttcctg 1560
gtggaagagg ataagaagca cgagcggcac cccatcttcg gcaacatcgt ggacgaggtg 1620
gcctaccacg agaagtaccc caccatctac cacctgagaa agaaactggt ggacagcacc 1680
gacaaggccg acctgcggct gatctatctg gccctggccc acatgatcaa gttccggggc 1740
cacttcctga tcgagggcga cctgaacccc gacaacagcg acgtggacaa gctgttcatc 1800
cagctggtgc agacctacaa ccagctgttc gaggaaaacc ccatcaacgc cagcggcgtg 1860
gacgccaagg ccatcctgtc tgccagactg agcaagagca gacggctgga aaatctgatc 1920
gcccagctgc ccggcgagaa gaagaatggc ctgttcggaa acctgattgc cctgagcctg 1980
ggcctgaccc ccaacttcaa gagcaacttc gacctggccg aggatgccaa actgcagctg 2040
agcaaggaca cctacgacga cgacctggac aacctgctgg cccagatcgg cgaccagtac 2100
gccgacctgt ttctggccgc caagaacctg tccgacgcca tcctgctgag cgacatcctg 2160
agagtgaaca ccgagatcac caaggccccc ctgagcgcct ctatgatcaa gagatacgac 2220
gagcaccacc aggacctgac cctgctgaaa gctctcgtgc ggcagcagct gcctgagaag 2280
tacaaagaga ttttcttcga ccagagcaag aacggctacg ccggctacat tgacggcgga 2340
gccagccagg aagagttcta caagttcatc aagcccatcc tggaaaagat ggacggcacc 2400
gaggaactgc tcgtgaagct gaacagagag gacctgctgc ggaagcagcg gaccttcgac 2460
aacggcagca tcccccacca gatccacctg ggagagctgc acgccattct gcggcggcag 2520
gaagattttt acccattcct gaaggacaac cgggaaaaga tcgagaagat cctgaccttc 2580
cgcatcccct actacgtggg ccctctggcc aggggaaaca gcagattcgc ctggatgacc 2640
agaaagagcg aggaaaccat caccccctgg aacttcgagg aagtggtgga caagggcgct 2700
tccgcccaga gcttcatcga gcggatgacc aacttcgata agaacctgcc caacgagaag 2760
gtgctgccca agcacagcct gctgtacgag tacttcaccg tgtataacga gctgaccaaa 2820
gtgaaatacg tgaccgaggg aatgagaaag cccgccttcc tgagcggcga gcagaaaaag 2880
gccatcgtgg acctgctgtt caagaccaac cggaaagtga ccgtgaagca gctgaaagag 2940
gactacttca agaaaatcga gtgcttcgac tccgtggaaa tctccggcgt ggaagatcgg 3000
ttcaacgcct ccctgggcac ataccacgat ctgctgaaaa ttatcaagga caaggacttc 3060
ctggacaatg aggaaaacga ggacattctg gaagatatcg tgctgaccct gacactgttt 3120
gaggacagag agatgatcga ggaacggctg aaaacctatg cccacctgtt cgacgacaaa 3180
gtgatgaagc agctgaagcg gcggagatac accggctggg gcaggctgag ccggaagctg 3240
atcaacggca tccgggacaa gcagtccggc aagacaatcc tggatttcct gaagtccgac 3300
ggcttcgcca acagaaactt catgcagctg atccacgacg acagcctgac ctttaaagag 3360
gacatccaga aagcccaggt gtccggccag ggcgatagcc tgcacgagca cattgccaat 3420
ctggccggca gccccgccat taagaagggc atcctgcaga cagtgaaggt ggtggacgag 3480
ctcgtgaaag tgatgggccg gcacaagccc gagaacatcg tgatcgaaat ggccagagag 3540
aaccagacca cccagaaggg acagaagaac agccgcgaga gaatgaagcg gatcgaagag 3600
ggcatcaaag agctgggcag ccagatcctg aaagaacacc ccgtggaaaa cacccagctg 3660
cagaacgaga agctgtacct gtactacctg cagaatgggc gggatatgta cgtggaccag 3720
gaactggaca tcaaccggct gtccgactac gatgtggacc atatcgtgcc tcagagcttt 3780
ctgaaggacg actccatcga caacaaggtg ctgaccagaa gcgacaagaa ccggggcaag 3840
agcgacaacg tgccctccga agaggtcgtg aagaagatga agaactactg gcggcagctg 3900
ctgaacgcca agctgattac ccagagaaag ttcgacaatc tgaccaaggc cgagagaggc 3960
ggcctgagcg aactggataa ggccggcttc atcaagagac agctggtgga aacccggcag 4020
atcacaaagc acgtggcaca gatcctggac tcccggatga acactaagta cgacgagaat 4080
gacaagctga tccgggaagt gaaagtgatc accctgaagt ccaagctggt gtccgatttc 4140
cggaaggatt tccagtttta caaagtgcgc gagatcaaca actaccacca cgcccacgac 4200
gcctacctaa acgccgtcgt gggaaccgcc ctgatcaaaa agtaccctaa gctggaaagc 4260
gagttcgtgt acggcgacta caaggtgtac gacgtgcgga agatgatcgc caagagcgag 4320
caggaaatcg gcaaggctac cgccaagtac ttcttctaca gcaacatcat gaactttttc 4380
aagaccgaga ttaccctggc caacggcgag atccggaagc ggcctctgat cgagacaaac 4440
ggcgaaaccg gggagatcgt gtgggataag ggccgggatt ttgccaccgt gcggaaagtg 4500
ctgagcatgc cccaagtgaa tatcgtgaaa aagaccgagg tgcagacagg cggcttcagc 4560
aaagagtcta tcctgcccaa gaggaacagc gataagctga tcgccagaaa gaaggactgg 4620
gaccctaaga agtacggcgg cttcgacagc cccaccgtgg cctattctgt gctggtggtg 4680
gccaaagtgg aaaagggcaa gtccaagaaa ctgaagagtg tgaaagagct gctggggatc 4740
accatcatgg aaagaagcag cttcgagaag aatcccatcg actttctgga agccaagggc 4800
tacaaagaag tgaaaaagga cctgatcatc aagctgccta agtactccct gttcgagctg 4860
gaaaacggcc ggaagagaat gctggcctct gccggcgaac tgcagaaggg aaacgaactg 4920
gccctgccct ccaaatatgt gaacttcctg tacctggcca gccactatga gaagctgaag 4980
ggctcccccg aggataatga gcagaaacag ctgtttgtgg aacagcacaa gcactacctg 5040
gacgagatca tcgagcagat cagcgagttc tccaagagag tgatcctggc cgacgctaat 5100
ctggacaaag tgctgtccgc ctacaacaag caccgggata agcccatcag agagcaggcc 5160
gagaatatca tccacctgtt taccctgacc aatctgggag cccctgccgc cttcaagtac 5220
tttgacacca ccatcgaccg gaagaggtac accagcacca aagaggtgct ggacgccacc 5280
ctgatccacc agagcatcac cggcctgtac gagacacgga tcgacctgtc tcagctggga 5340
ggtgacagcg gcgggagcgg cgggagcggg gggagcacta atctgagcga catcattgag 5400
aaggagactg ggaaacagct ggtcattcag gagtccatcc tgatgctgcc tgaggaggtg 5460
gaggaagtga tcggcaacaa gccagagtct gacatcctgg tgcacaccgc ctacgacgag 5520
tccacagatg agaatgtgat gctgctgacc tctgacgccc ccgagtataa gccttgggcc 5580
ctggtcatcc aggattctaa cggcgagaat aagatcaaga tgctgagcgg aggatccgga 5640
ggatctggag gcagcaccaa cctgtctgac atcatcgaga aggagacagg caagcagctg 5700
gtcatccagg agagcatcct gatgctgccc gaagaagtcg aagaagtgat cggaaacaag 5760
cctgagagcg atatcctggt ccataccgcc tacgacgaga gtaccgacga aaatgtgatg 5820
ctgctgacat ccgacgcccc agagtataag ccctgggctc tggtcatcca ggattccaac 5880
ggagagaaca aaatcaaaat gctgtctggc ggctcaaaaa gaaccgccga cggcagcgaa 5940
ttcgagccca agaagaagag gaaagtctaa ccggtcatca tcaccatcac cattgagttt 6000
aaacccgctg atcagcctcg actgtgcctt ctagttgcca gccatctgtt gtttgcccct 6060
cccccgtgcc ttccttgacc ctggaaggtg ccactcccac tgtcctttcc taataaaatg 6120
aggaaattgc atcgcattgt ctgagtaggt gtcattctat tctggggggt ggggtggggc 6180
aggacagcaa gggggaggat tgggaagaca atagcaggca tgctggggat gcggtgggct 6240
ctatggcttc tgaggcggaa agaaccagct ggggctcgat accgtcgacc tctagctaga 6300
gcttggcgta atcatggtca tagctgtttc ctgtgtgaaa ttgttatccg ctcacaattc 6360
cacacaacat acgagccgga agcataaagt gtaaagccta ggatgcctaa tgagtgagct 6420
aactcacatt aattgcgttg cgctcactgc ccgctttcca gtcgggaaac ctgtcgtgcc 6480
agctgcatta atgaatcggc caacgcgcgg gaagaggcgg tttgcgtatt gggcgctctt 6540
ccgcttcctc gctcactgac tcgctgcgct cggtcgttcg gctgcggcga gcggtatcag 6600
ctcactcaaa ggcggtaata cggttatcca cagaatcagg ggataacgca ggaaagaaca 6660
tgtgagcaaa aggccagcaa aaggccagga accgtaaaaa ggccgcgttg ctggcgtttt 6720
tccataggct ccgcccccct gacgagcatc acaaaaatcg acgctcaagt cagaggtggc 6780
gaaacccgac aggactataa agataccagg cgtttccccc tggaagctcc ctcgtgcgct 6840
ctcctgttcc gaccctgccg cttaccggat acctgtccgc ctttctccct tcgggaagcg 6900
tggcgctttc tcatagctca cgctgtaggt atctcagttc ggtgtaggtc gttcgctcca 6960
agctgggctg tgtgcacgaa ccccccgttc agcccgaccg ctgcgcctta tccggtaact 7020
atcgtcttga gtccaacccg gtaagacacg acttatcgcc actggcagca gccactggta 7080
acaggattag cagagcgagg tatgtaggcg gtgctacaga gttcttgaag tggtggccta 7140
actacggcta cactagaaga acagtatttg gtatctgcgc tctgctgaag ccagttacct 7200
tcggaaaaag agttggtagc tcttgatccg gcaaacaaac caccgctggt agcggtggtt 7260
tttttgtttg caagcagcag attacgcgca gaaaaaaagg atctcaagaa gatcctttga 7320
tcttttctac ggggtctgac actcagtgga acgaaaactc acgttaaggg attttggtca 7380
tgagattatc aaaaaggatc ttcacctaga tccttttaaa ttaaaaatga agttttaaat 7440
caatctaaag tatatatgag taaacttggt ctgacagtta ccaatgctta atcagtgagg 7500
cacctatctc agcgatctgt ctatttcgtt catccatagt tgcctgactc cccgtcgtgt 7560
agataactac gatacgggag ggcttaccat ctggccccag tgctgcaatg ataccgcgag 7620
acccacgctc accggctcca gatttatcag caataaacca gccagccgga agggccgagc 7680
gcagaagtgg tcctgcaact ttatccgcct ccatccagtc tattaattgt tgccgggaag 7740
ctagagtaag tagttcgcca gttaatagtt tgcgcaacgt tgttgccatt gctacaggca 7800
tcgtggtgtc acgctcgtcg tttggtatgg cttcattcag ctccggttcc caacgatcaa 7860
ggcgagttac atgatccccc atgttgtgca aaaaagcggt tagctccttc ggtcctccga 7920
tcgttgtcag aagtaagttg gccgcagtgt tatcactcat ggttatggca gcactgcata 7980
attctcttac tgtcatgcca tccgtaagat gcttttctgt gactggtgag tactcaacca 8040
agtcattctg agaatagtgt atgcggcgac cgagttgctc ttgcccggcg tcaatacggg 8100
ataataccgc gccacatagc agaactttaa aagtgctcat cattggaaaa cgttcttcgg 8160
ggcgaaaact ctcaaggatc ttaccgctgt tgagatccag ttcgatgtaa cccactcgtg 8220
cacccaactg atcttcagca tcttttactt tcaccagcgt ttctgggtga gcaaaaacag 8280
gaaggcaaaa tgccgcaaaa aagggaataa gggcgacacg gaaatgttga atactcatac 8340
tcttcctttt tcaatattat tgaagcattt atcagggtta ttgtctcatg agcggataca 8400
tatttgaatg tatttagaaa aataaacaaa taggggttcc gcgcacattt ccccgaaaag 8460
tgccacctga cgtcgacgga tcgggagatc gatctcccga tcccctaggg tcgactctca 8520
gtacaatctg ctctgatgcc gcatagttaa gccagtatct gctccctgct tgtgtgttgg 8580
aggtcgctga gtagtgcgcg agcaaaattt aagctacaac aaggcaaggc ttgaccgaca 8640
attgcatgaa gaatctgctt agggttaggc gttttgcgct gcttcgcgat gtacgggcca 8700
gatatacgcg ttgacattga ttattgacta gttattaata gtaatcaatt acggggtcat 8760
tagttcatag cccatatatg gagttccgcg ttacataact tacggtaaat ggcccgcctg 8820
gctgaccgcc caacgacccc cgcccattga cgtcaataat gacgtatgtt cccatagtaa 8880
cgccaatagg gactttccat tgacgtcaat gggtggagta tttacggtaa actgcccact 8940
tggcagtaca tcaagtgtat c 8961

Claims (7)

1. a kind of gene knockout method, comprising:
According to the translation initiation region sequence characteristic of gene to be knocked out, 20bp-NGG or CCN-20bp target sequence is designed, its packet is made Containing complete initiation codon ATG;
ABE or BE4 navigated into target sequence using sgRNA sequence so that target single base A, T or G in initiation codon It is mutated into G, C or A, so that initiation codon be made to lose function, reaches and target gene is knocked out;
If PAM is NGG, ATG is sported into GTG using ABE, if PAM is CCN, ATG is sported into ACG using ABE, or ATG is sported into ATA using BE4.According to specific catastrophe, if target single base A or T are preferably placed at target sequence using ABE 4-7 of column, if target single base G is preferably placed at 4-8 of target sequence using BE4;The sgRNA sequence be with The complementary corresponding 20bp sequence of target sequence.
2. according to the method described in claim 1, wherein ABE is selected from pCMV-ABEmax
BE4 is selected from: pCMV-AncBE4max, pCMV-BE4max.
3. according to the method described in claim 1, for knocking out following 11 target genes: people APOE, PD1, LAG3, TIGIT, VISTA, CD224, CD160, SOX9, HDAC1 and mouse TIM3 and LAG3, its corresponding sgRNA sequence respectively with sequence Target gene sequence shown in one to ten is complementary.
4. claim 1 the method cell line HEK293T carry out people APOE, PD1, LAG3, TIGIT, VISTA, CD224, The application of CD160, SOX9, HDAC1 gene knockout.
5. claim 1 the method human T-cell carry out people APOE, PD1, LAG3, TIGIT, VISTA, CD224, CD160, The application of SOX9, HDAC1 gene knockout.
6. the isolated T cell or cell line or their subculture obtained according to the application of claim 4 or 5.
7. a kind of kit for gene knockout, including sgRNA, ABE, BE4 described in claims 1 or 2 and amplification Reagent.
CN201910105331.4A 2019-02-01 2019-02-01 Method for realizing gene knockout based on base editing system mutation initiation codon and application Active CN109706185B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910105331.4A CN109706185B (en) 2019-02-01 2019-02-01 Method for realizing gene knockout based on base editing system mutation initiation codon and application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910105331.4A CN109706185B (en) 2019-02-01 2019-02-01 Method for realizing gene knockout based on base editing system mutation initiation codon and application

Publications (2)

Publication Number Publication Date
CN109706185A true CN109706185A (en) 2019-05-03
CN109706185B CN109706185B (en) 2021-07-27

Family

ID=66264246

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910105331.4A Active CN109706185B (en) 2019-02-01 2019-02-01 Method for realizing gene knockout based on base editing system mutation initiation codon and application

Country Status (1)

Country Link
CN (1) CN109706185B (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110029096A (en) * 2019-05-09 2019-07-19 上海科技大学 A kind of adenine base edit tool and application thereof
CN110407945A (en) * 2019-06-14 2019-11-05 上海科技大学 A kind of adenine base edit tool and application thereof
CN114058639A (en) * 2021-10-29 2022-02-18 中国种子集团有限公司 Method for improving content of amylose in rice by using single-base gene editing technology to mutate OsWaxy gene
CN114561429A (en) * 2022-03-22 2022-05-31 绍兴市妇幼保健院 Treatment method for inhibiting HBV surface antigen based on base editing ATG initiation codon
CN114561392A (en) * 2022-03-22 2022-05-31 绍兴市妇幼保健院 Method for removing HBV e antigen by closing target gene based on base editing technology
CN117126818A (en) * 2023-10-25 2023-11-28 江西农业大学 Method for constructing gE gene deletion PRV strain by utilizing ABE and application
WO2024012300A1 (en) * 2022-07-11 2024-01-18 上海贝斯昂科生物科技有限公司 Gene editing method and use

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107164377A (en) * 2017-06-12 2017-09-15 王小平 Gene knockout method and its application based on base editor
WO2018039438A1 (en) * 2016-08-24 2018-03-01 President And Fellows Of Harvard College Incorporation of unnatural amino acids into proteins using base editing
CN108513575A (en) * 2015-10-23 2018-09-07 哈佛大学的校长及成员们 Nucleobase editing machine and application thereof
CN108753823A (en) * 2018-06-20 2018-11-06 李广磊 The method and its application of gene knockout are realized using base editing technique

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108513575A (en) * 2015-10-23 2018-09-07 哈佛大学的校长及成员们 Nucleobase editing machine and application thereof
WO2018039438A1 (en) * 2016-08-24 2018-03-01 President And Fellows Of Harvard College Incorporation of unnatural amino acids into proteins using base editing
CN107164377A (en) * 2017-06-12 2017-09-15 王小平 Gene knockout method and its application based on base editor
CN108753823A (en) * 2018-06-20 2018-11-06 李广磊 The method and its application of gene knockout are realized using base editing technique

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
XINJIE WANG,ET AL.: "Efficient Gene Silencing by Adenine Base Editor Mediated Started Codon Mutation", 《MOLECULAR THERAPY》 *

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110029096A (en) * 2019-05-09 2019-07-19 上海科技大学 A kind of adenine base edit tool and application thereof
CN110029096B (en) * 2019-05-09 2023-05-12 上海科技大学 Adenine base editing tool and application thereof
CN110407945A (en) * 2019-06-14 2019-11-05 上海科技大学 A kind of adenine base edit tool and application thereof
CN114058639A (en) * 2021-10-29 2022-02-18 中国种子集团有限公司 Method for improving content of amylose in rice by using single-base gene editing technology to mutate OsWaxy gene
CN114058639B (en) * 2021-10-29 2023-11-07 中国种子集团有限公司 Method for improving amylose content of rice by mutating OsWaxy gene by single base gene editing technology
CN114561429A (en) * 2022-03-22 2022-05-31 绍兴市妇幼保健院 Treatment method for inhibiting HBV surface antigen based on base editing ATG initiation codon
CN114561392A (en) * 2022-03-22 2022-05-31 绍兴市妇幼保健院 Method for removing HBV e antigen by closing target gene based on base editing technology
WO2024012300A1 (en) * 2022-07-11 2024-01-18 上海贝斯昂科生物科技有限公司 Gene editing method and use
CN117126818A (en) * 2023-10-25 2023-11-28 江西农业大学 Method for constructing gE gene deletion PRV strain by utilizing ABE and application
CN117126818B (en) * 2023-10-25 2024-02-02 江西农业大学 Method for constructing gE gene deletion PRV strain by utilizing ABE and application

Also Published As

Publication number Publication date
CN109706185B (en) 2021-07-27

Similar Documents

Publication Publication Date Title
CN109706185B (en) Method for realizing gene knockout based on base editing system mutation initiation codon and application
CN107557388B (en) Lentiviral vector for CAR-T preparation and construction method and application thereof
CN108271384A (en) The molecular complex that the method for converting of the genome sequence of the gram-positive bacteria of the nucleic acid base of DNA sequence dna is targeted for special sex reversal and its is used
CN113403294B (en) Fusion protein, base editing tool and application thereof
CN108410787A (en) A kind of recombined bacillus subtilis of synthesis new tetroses of lactoyl-N- and its construction method and application
KR20100051632A (en) Fsh producing cell clone
CN108949693A (en) A kind of pair of T cell immune detection point access carries out the method and application of gene knockout
CN114196705B (en) Recombinant adeno-associated virus packaging plasmid, recombinant adeno-associated virus and application thereof
CN110938651A (en) Targeting vector, method for constructing BAC clone by targeting and integrating exogenous gene to mouse F4/80 exon 22 site and application
CN113943720A (en) Apolygus lucorum GRK gene, dsRNA thereof, synthetic method and application thereof
CN107287201B (en) Strong broad-spectrum promoter and application thereof
US20010010928A1 (en) Protozoan expression system
CN111500641A (en) Preparation method of pig with human nerve growth factor gene
KR102009273B1 (en) Recombinant foot-and-mouth disease virus expressing protective antigen of type O-TAW97
CN114736308B (en) Preparation and application of coccidian antigen peptide/IL 5 fusion protein gene engineering bacteria
KR100721140B1 (en) Shuttle vectors for Leuconostoc and E. coli
KR101535070B1 (en) Recomnication expression vector of vascular growth factor and the vascular growth factor expressing stem cell line thereof
CN110129366B (en) Carrier combination and application thereof
KR101891602B1 (en) Recombinant foot-and-mouth disease virus expressing protective antigen of type O, SEA and ME-SA topotype
KR20170017115A (en) Method of testing genotype and phenotype for simultaneously predicting drug resistance against protease inhibitor, reverse transcriptase inhibitor and integrase inhibitor
CN114181939B (en) Recombinant coccidium vector expressing NA4 protein and fluorescent tag and detection method thereof
CN109852589A (en) A kind of clone of cymbidium mosaic virus strain and its transcription vector building
CN112852651B (en) Method for increasing yield of hydrocortisone produced by saccharomyces cerevisiae biotransformation
KR102009265B1 (en) Recombinant foot-and-mouth disease virus expressing protective antigen of type SAT1 BOT
CN110499314B (en) Protein eukaryotic expression promoter, protein expression vector, construction method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information

Address after: 100081 Beijing city Haidian District Dahui Temple Road, No. 12

Applicant after: Institute of Science and Technology, National Health Commission

Address before: 100081 Beijing city Haidian District Dahui Temple Road, No. 12

Applicant before: RESEARCH INSTITUTE OF PRC NATIONAL HEALTH AND FAMILY PLANNING COMMISSION

CB02 Change of applicant information
GR01 Patent grant
GR01 Patent grant